41 results on '"Krafft, Ulrich"'
Search Results
2. Cumulative sum analysis (CUSUM) for evaluating learning curve (LC) of robotic-assisted laparoscopic partial nephrectomy (RALPN)
3. Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis
4. Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial
5. The impact of double-J ureteral stenting before radical cystectomy on the development of upper tract urothelial carcinoma.
6. Bricker versus Wallace ureteroileal anastomosis: A multi‐institutional propensity score‐matched analysis.
7. High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
8. Kombination von Avelumab und stereotaktischer ablativer Bestrahlung beim metastasierten kastrationsresistenten Prostatakarzinom: Effektivität und Sicherheit – Phase II ICE-PAC
9. A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
10. Near‐infrared fluorescence lymph node template region dissection plus backup lymphadenectomy in open radical cystectomy for bladder cancer using an innovative handheld device: A single center experience.
11. Nuclear Localization of Robo is Associated with Better Survival in Bladder Cancer
12. A randomized phase I/II study of neoadjuvant treatment with 177 -Lutetium-PSMA-617 with or without ipilimumab in patients with very high-risk prostate cancer who are candidates for radical prostatectomy (NEPI trial).
13. Risk factors for ureteroenteric stricture after radical cystectomy and urinary diversion: A systematic review.
14. Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer
15. Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry.
16. Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy Specimens
17. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer
18. 18F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men.
19. Preparing next Actions in Routine Activities
20. Three-dimensional Magnetic Resonance Imaging–based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy—A Feasibility Study
21. Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer.
22. High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma.
23. SYSTÈME ÉCRIVANT ET PROCESSUS DE MISE EN MOTS DANS LES RÉDACTIONS CONVERSATIONNELLES
24. Long-term adjuvant administration of temozolomide in patients with glioblastoma multiforme: experience of a single institution
25. A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?
26. Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort.
27. Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma.
28. Radiation Protection and Occupational Exposure on [68Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures in robot assisted Prostatectomy.
29. Implementation of radioguided surgery in prostate cancer.
30. The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate Cancer.
31. Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
32. Preparing Next Actions in Routine Activities.
33. High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy.
34. Franco‐West German technological co‐operation.
35. Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients.
36. Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer.
37. Risk factors for ureteroenteric stricture after radical cystectomy and urinary diversion: A systematic review.
38. 18 F-PSMA Cerenkov Luminescence and Flexible Autoradiography Imaging in a Prostate Cancer Mouse Model and First Results of a Radical Prostatectomy Feasibility Study in Men.
39. Radiation Protection and Occupational Exposure on 68 Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted Prostatectomy.
40. [Combining avelumab and stereotactic ablative body radiotherapy in metastatic castration-resistant prostate cancer : Efficacy and safety-phase II ICE-PAC].
41. Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging-utilization of a short-pass filter to reduce technical pitfalls.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.